A Personal Mission for a Global Problem
The scientific breakthrough at UVA is also a story of international collaboration and personal dedication. For lead author Godfrey Dzhivhuho, the quest for an HIV cure is deeply personal.
Dzhivhuho’s journey to the University of Virginia began years ago in South Africa, a nation that has been disproportionately affected by the HIV epidemic. Currently, more than 8 million people in South Africa are living with the virus. Dzhivhuho first met Rekosh and Hammarskjold when the two UVA professors were teaching summer sessions at the University of Venda.
Inspired by the potential to make a difference in his home country and beyond, Dzhivhuho pursued his PhD in HIV immunology at the University of Cape Town. He eventually joined the Thaler Center at UVA, bringing his expertise and firsthand understanding of the epidemic’s impact to the laboratory.
"Coming from South Africa, where HIV affects so many lives, I’ve always wanted to be part of the effort to end this epidemic," Dzhivhuho said. "I hope this work brings us one step closer to a cure, not just by uncovering how the virus works, but by helping design smarter strategies to finally eliminate it. That’s what drives me every day in this research."
The Path Forward
The UVA findings represent a significant shift in how researchers view the lifecycle of HIV. By moving away from the "on-off" switch model and embracing the complexity of the Rev-RRE rheostat, the scientific community can begin to develop more tailored interventions.
Future research will likely focus on finding molecular tools that can manipulate this rheostat. If scientists can learn how to artificially "turn up" the Rev-RRE activity in latent cells, they may finally be able to expose the entire viral reservoir to the immune system.
The work conducted at the University of Virginia School of Medicine was a collaborative effort supported by the Myles H. Thaler Research Support Gift and several grants from the National Institutes of Health (NIH), including grants R21 AI134208 and K08 AI136671. As these researchers continue their work, the goal remains clear: to move beyond the management of HIV and toward a definitive end to the epidemic.
The discovery of the Rev-RRE rheostat does not provide a cure overnight, but it provides something equally essential: a clearer understanding of the enemy’s defenses. In the long and difficult battle against HIV, knowing exactly how the virus hides is the first step toward making sure it has nowhere left to run.
